制造商: 药理分类: 活性成分(补): 另外: 药理作用: 临床试验: 法律分类: 成人: 儿童: 禁忌(补): 警告/注意事项: 互动(补): 如何提供: 最后更新: DULERA Generic Name for DULERA 100/5Mometasone furoate 100mcg, formoterol fumarate dihydrate 5mcg; per inh; metered-dose inhaler; contains HFA. Legal Classification:Rx Pharmacological Class for DULERA 100/5Steroid + long-acting β2-agonist. Manufacturer of DULERA 100/5Merck & Co., Inc. Indications for DULERA 100/5Maintenance treatment of asthma in patients not adequately controlled on other asthma-controller medications or whose disease severity warrants initiation of both an inhaled steroid and a long acting β2-agonist. Adult dose for DULERA 100/5Previously on medium dose of steroid: use 100/5 strength; previously on high dose of steroid: use 200/5 strength. For both: Two inhalations twice daily (AM & PM). Rinse mouth after use. Children's dosing for DULERA 100/5Not recommended. Also:DULERA 200/5
Contraindications for DULERA 100/5Not for acute asthma attacks. Warnings/Precautions for DULERA 100/5Long-acting β2-adrenergic agonist may increase the risk of asthma-related death. Do not exceed recommended dose. Not for use with other long-acting β2-agonists. Transferring from systemic steroids: taper gradually. Do not initiate in significantly or acutely deteriorating asthma. Cardiovascular disease (especially coronary insufficiency, arrhythmias, hypertension). Hyperthyroidism. Convulsive disorders. Hepatic impairment. Hyperresponsiveness to sympathomimetics. Diabetes. Ketoacidosis. Immunosuppressed. Untreated infections, TB, ocular herpes. If exposed to chickenpox or measles, consider anti-infective prophylactic therapy. If adrenal insufficiency exists following systemic corticosteroid therapy, replacement with inhaled corticosteroids may exacerbate symptoms of adrenal insufficiency (eg, lassitude). Prescribe a short-acting, inhaled β2-agonist for acute symptoms; monitor for increased need. Monitor potassium, intraocular pressure; bone mineral density if other osteoporosis risk factors exist; and for growth suppression in children; hypercorticism and HPA axis suppression (if occurs, discontinue gradually). Labor & delivery. Do not use with spacers. Pregnancy (Cat.C). Nursing mothers: not recommended. Interactions for DULERA 100/5Concomitant other long-acting β2-agonists (eg, formoterol, arformoterol, salmeterol): not recommended. Avoid within 2 weeks of MAOIs, tricyclic antidepressants, drugs that prolong QTc (increased cardiac effects). Caution with other sympathomimetics (except short-acting bronchodilators). Mometasone systemic effects may be potentiated by concomitant potent CYP3A4 inhibitors (eg, ketoconazole, ritonavir). Hypokalemia potentiated by xanthines, steroids, K+-depleting diuretics. Antagonized by β-blockers. Adverse Reactions for DULERA 100/5Nasopharyngitis, sinusitis, headache, candidiasis, β2-agonist effects (eg, hypokalemia, hyperglycemia), paradoxical bronchospasm; rarely: serious asthma episode, asthma-related death. How is DULERA 100/5 supplied?Inhaler—13g (120 inh) |
Dulera(莫米松/福莫特罗)气雾剂简介:
2010年6月24日,默克宣布Dulera(mometasonefuroate和formoterolfumaratedihydrate的联用剂型)吸入型喷雾剂已经获得美国食品药品监督管理局批准上市,该药物为新型联用剂型,是一种含有皮质类固醇(糠酸 ... 责任编辑:admin
|
最新文章更多推荐文章更多热点文章更多 |